A Single-Blind Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and beta-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes).
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Colesevelam (Primary)
- Indications Glucose intolerance
- Focus Pharmacodynamics
- 16 Dec 2011 Actual patient number (21) and actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 16 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2010 Planned end date changed from 1 Jul 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.